11 Apr TRAINM welcomes Stefan Yee as chairman of the board of directors
Antwerp, 11 April 2022 – TRAINM announces that Stefan Yee has been elected Chairman of the Board of Directors of TRAINM, a leading outpatient Neuro (post) Rehabilitation group, with clinics in Antwerp and Ghent-South (Zottegem).
Stefan Yee has more than 30 years of experience in audit, corporate law, M&A, corporate finance, investment banking and private equity with companies as KPMG, Linklaters, Lessius, FPIM International, Beluga (Euronext) and as the founder and CEO of PE Group, a Belgian privately held general private equity firm.
Stefan Yee is and has been an investor and/or board member of several private and listed companies in various industries, including at present, amongst others, as Chairman of Unifiedpost Group (Euronext), Hyloris Pharmaceuticals (Euronext) and Axiles Bionics.
Stefan holds Master degrees in Law and Management from the Universities of Brussels (VUB and ULB Solvay Business School) and the University of Chicago Law School (as a BAEF Hoover Foundation Fellow).
“Given TRAINM’s strong growth trajectory with the opening of additional clinics in Belgium and the Netherlands, the private equity, corporate finance and corporate governance experience of Stefan will be paramount for TRAINM” says Edward Schiettecatte, Co-founder and CEO of TRAINM.
Stefan Yee commented: “I’m truly honored, grateful and motivated to continue to support and guide TRAINM as Chairman in its ambition to become a leading European reference Neuro Rehabilitation group. TRAINM, is an unique, privately funded, innovative company with a mission to improve and impact the physical, mental and social wellbeing of children and adults with neurological deficits.
About TRAINM
TRAINM is a leading outpatient neuro (post) rehabilitation group, with clinics in Antwerp and Ghent-South (Zottegem), Belgium, treating children and adults with a neurological disorder, e.g. cerebral palsy, acquired brain injury, stroke, multiple sclerosis, Parkinson’s disease, spinal cord injury and disorders of consciousness. The clinic’s personalized, intensive treatment programs combine various scientific disciplines and use innovative technologies such as robotics, virtual reality, neurogaming, artificial intelligence and non-invasive neuromodulation.
www.trainm.com
Contact
Edward Schiettecatte, CEO TRAINM, info@trainm.com, +32.474.30.52.87
